198 related articles for article (PubMed ID: 20930294)
1. Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI.
Aluise CD; Robinson RA; Cai J; Pierce WM; Markesbery WR; Butterfield DA
J Alzheimers Dis; 2011; 23(2):257-69. PubMed ID: 20930294
[TBL] [Abstract][Full Text] [Related]
2. Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease.
Triplett JC; Swomley AM; Cai J; Klein JB; Butterfield DA
J Alzheimers Dis; 2016; 49(1):45-62. PubMed ID: 26444780
[TBL] [Abstract][Full Text] [Related]
3. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
[TBL] [Abstract][Full Text] [Related]
4. Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.
Aluise CD; Robinson RA; Beckett TL; Murphy MP; Cai J; Pierce WM; Markesbery WR; Butterfield DA
Neurobiol Dis; 2010 Aug; 39(2):221-8. PubMed ID: 20399861
[TBL] [Abstract][Full Text] [Related]
5. Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.
Owen JB; Di Domenico F; Sultana R; Perluigi M; Cini C; Pierce WM; Butterfield DA
J Proteome Res; 2009 Feb; 8(2):471-82. PubMed ID: 19072283
[TBL] [Abstract][Full Text] [Related]
6. Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease.
Sultana R; Banks WA; Butterfield DA
J Neurosci Res; 2010 Feb; 88(3):469-77. PubMed ID: 19774677
[TBL] [Abstract][Full Text] [Related]
7. Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease.
Sultana R; Perluigi M; Newman SF; Pierce WM; Cini C; Coccia R; Butterfield DA
Antioxid Redox Signal; 2010 Mar; 12(3):327-36. PubMed ID: 19686046
[TBL] [Abstract][Full Text] [Related]
8. Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease.
Cenini G; Sultana R; Memo M; Butterfield DA
Free Radic Biol Med; 2008 Jul; 45(1):81-5. PubMed ID: 18439434
[TBL] [Abstract][Full Text] [Related]
9. Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer's disease mice at its earliest pathological stage.
Shen L; Chen C; Yang A; Chen Y; Liu Q; Ni J
J Proteomics; 2015 Jun; 123():101-13. PubMed ID: 25890254
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.
Butterfield DA; Reed TT; Perluigi M; De Marco C; Coccia R; Keller JN; Markesbery WR; Sultana R
Brain Res; 2007 May; 1148():243-8. PubMed ID: 17395167
[TBL] [Abstract][Full Text] [Related]
11. Alterations in zinc transporter protein-1 (ZnT-1) in the brain of subjects with mild cognitive impairment, early, and late-stage Alzheimer's disease.
Lovell MA; Smith JL; Xiong S; Markesbery WR
Neurotox Res; 2005; 7(4):265-71. PubMed ID: 16179263
[TBL] [Abstract][Full Text] [Related]
12. Abeta solubility and deposition during AD progression and in APPxPS-1 knock-in mice.
Murphy MP; Beckett TL; Ding Q; Patel E; Markesbery WR; St Clair DK; LeVine H; Keller JN
Neurobiol Dis; 2007 Sep; 27(3):301-11. PubMed ID: 17651976
[TBL] [Abstract][Full Text] [Related]
13. Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment.
Dugger BN; Davis K; Malek-Ahmadi M; Hentz JG; Sandhu S; Beach TG; Adler CH; Caselli RJ; Johnson TA; Serrano GE; Shill HA; Belden C; Driver-Dunckley E; Caviness JN; Sue LI; Jacobson S; Powell J; Sabbagh MN
BMC Neurol; 2015 Aug; 15():146. PubMed ID: 26289075
[TBL] [Abstract][Full Text] [Related]
14. Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD.
Sabbagh MN; Cooper K; DeLange J; Stoehr JD; Thind K; Lahti T; Reisberg B; Sue L; Vedders L; Fleming SR; Beach TG
Curr Alzheimer Res; 2010 Jun; 7(4):280-6. PubMed ID: 19715548
[TBL] [Abstract][Full Text] [Related]
15. Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study.
Sultana R; Reed T; Perluigi M; Coccia R; Pierce WM; Butterfield DA
J Cell Mol Med; 2007; 11(4):839-51. PubMed ID: 17760844
[TBL] [Abstract][Full Text] [Related]
16. Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease.
Bader Lange ML; Cenini G; Piroddi M; Abdul HM; Sultana R; Galli F; Memo M; Butterfield DA
Neurobiol Dis; 2008 Mar; 29(3):456-64. PubMed ID: 18077176
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease.
Cenini G; Sultana R; Memo M; Butterfield DA
J Cell Mol Med; 2008 Jun; 12(3):987-94. PubMed ID: 18494939
[TBL] [Abstract][Full Text] [Related]
18. Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.
Sultana R; Perluigi M; Butterfield DA
Acta Neuropathol; 2009 Jul; 118(1):131-50. PubMed ID: 19288120
[TBL] [Abstract][Full Text] [Related]
19. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG
Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618
[TBL] [Abstract][Full Text] [Related]
20. Correlating cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre-mild cognitive impairment.
Caselli RJ; Chen K; Lee W; Alexander GE; Reiman EM
Arch Neurol; 2008 Sep; 65(9):1231-6. PubMed ID: 18779428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
